Skip to main content

Carbetapentane Pregnancy and Breastfeeding Warnings

Carbetapentane is also known as: Solotuss

Carbetapentane Pregnancy Warnings

Carbetapentane has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Carbetapentane is only recommended for use during pregnancy when benefit outweighs risk.

See references

Carbetapentane Breastfeeding Warnings

There are no data on the excretion of carbetapentane into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. solotuss (carbetapentane)." Hawthorn Pharmaceuticals (2007):

References for breastfeeding information

  1. "Product Information. solotuss (carbetapentane)." Hawthorn Pharmaceuticals (2007):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.